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Summary
The central dogma of mammalian brain sexual differ-
entiation has contended that sex steroids of gonadal
origin organize the neural circuits of the developing
brain [1]. Recent evidence has begun to challenge
this idea and has suggested that, independent of the
masculinizing effects of gonadal secretions, XY and
XX brain cells have different patterns of gene expres-
sion that influence their differentiation and function
[2]. We have previously shown that specific differ-
ences in gene expression exist between male and fe-
male developing brains and that these differences pre-
cede the influences of gonadal hormones [3]. Here we
demonstrate that the Y chromosome-linked, male-de-
termining gene Sry is specifically expressed in the
substantia nigra of the adult male rodent in tyrosine
hydroxylase-expressing neurons. Furthermore, using
antisense oligodeoxynucleotides, we show that Sry
downregulation in the substantia nigra causes a statis-
tically significant decrease in tyrosine hydroxylase ex-
pression with no overall effect on neuronal numbers
and that this decrease leads to motor deficits in male
rats. Our studies suggest that Sry directly affects the
biochemical properties of the dopaminergic neurons
of the nigrostriatal system and the specific motor be-
haviors they control. These results demonstrate a
direct male-specific effect on the brain by a gene en-
coded only in themale genome, without anymediation
by gonadal hormones.
*Correspondence: evilain@ucla.eduResults and Discussion
Localization of SRY in the Brain
To examine the expression of Sry mRNA in the adult
mouse brain, we analyzed consecutive coronal sections
by radioactive in situ hybridization. Specific labeling of
Srywas observed in the substantia nigra (SN) of the mid-
brain and the medial mammillary bodies (MMB) of the
hypothalamus of male, but not female, mice (Figures
1A–1C). Lower levels of Sry expression were observed
sparsely throughout the cortex. Primers that distinguish
between circular and linear Sry mRNA forms were used
[4] in RT-PCR, confirming that Sry mRNA transcripts in
the midbrain and cortex of the adult male brain were of
the linear form (data not shown). Examination of brains
of male and femaleSry-enhanced green fluorescent pro-
tein (EGFP) transgenic adult mice, in which 7.7 kb of the
Sry promoter drives the expression of the reporter EGFP
[5], also revealed positive Sry expression in the SN (Fig-
ures 1D and 1E). This observation confirms our in situ
hybridization results and suggests that regulatory se-
quences for brain expression of Sry are contained within
7.7 kb of the start transcription. These data are consis-
tent with previous reports of Sry expression in the adult
mouse hypothalamus, midbrain, and cortex [6, 7] but
provide a detailed survey of its expression.
Sry protein was observed in all regions of the SN, with
most SRY immunoreactive cells in the pars compacta
region of adult male mouse (Figure 1F [SNc]) and rat
brains (Figure S1). Sry staining was observed in both
the cytoplasm and the nucleus of cells; the nucleus is
the presumed site of action of SRY as a DNA binding
transcription factor. To determine whether SRY was co-
localized with tyrosine hydroxylase (TH) in the SN, we
performed double-label immunohistochemistry for
SRY and TH (Figure 1F). Ten percent of all cells (DAPI
stained) were SRY positive. All SRY-positive cells were
also TH-positive neurons. Thus, SRY protein is pro-
duced in the adult male mouse SN and is localized ex-
clusively in TH-positive neurons. Sry staining was ab-
sent in the female mouse SN. (Figure 1G).
Before evaluating the role of Sry function in the SN, we
first tested whether the number of TH neurons in the rat
SN was sexually dimorphic. In females, the number of
TH-ir neurons was 20% less than the number in age-
matched male controls (Figure 2C, p = 0.032). This indi-
cates that the expression of TH, the rate-limiting enzyme
of the dopaminergic pathway, is sexually dimorphic in
rats, which correlates with previous findings in mice [8].
Effects of Sry on TH Neurons in the SN and Striatum
To investigate the effect ofSry on TH neurons in vivo and
consequent motor behavior in rats, we specifically
downregulated Sry in the SN by an antisense targeting
method [9]. Sry antisense oligodeoxynucleotides (ODN;
see Table 1) were microinfused unilaterally into the
SNs of male rats. As a control, the contralateral SN
was infused with Sry sense ODN. Infusion of Sry
Current Biology
416Figure 1. Localization of Sry in Specific Regions of the Adult Mouse Brain
(A) In situ hybridization using either labeled antisense or sense Sry cRNA probes localized Sry expression specifically to the medial mammillary
bodies (MMB), substantia nigra (SN), and to a lesser extent in the cortex (CX).
(B) Control Sry sense probes revealed no signal in any regions on comparable sections in the adult male mouse brain.
(C) Antisense Sry probes revealed no specific hybridization in adult female mouse brains.
(D and E) Sry expression in the SN (E) was confirmed with Sry-EGFP transgenic mice. The box in panel (D) is indicative of the region represented
in (E).
(F) In the adult male mouse SN, Sry protein (green) localized to both the cytoplasm and nuclei of TH-ir neurons (red). The inset shows a repre-
sentative TH- and Sry-ir neuron (magnified). All cells in a representative field for Sry/TH co-labeling (n = 4923) were counted and scored. The scale
bar represents 25
(G) Sry staining was absent in adult female mouse SN.
The scale bar represents 100 mm (E) and 25 mm (F and G).antisense ODN into the SN reduced the number of TH-ir
neurons by 38% in comparison to the side infused with
sense ODN, as quantified with an optical fractionator
sampling design [10] (Figures 2A, 2B, and 2D, p =
0.0022). A higher magnification indicates that neural de-
generation in TH-positive cells had not occurred (Fig-
ure 2B, inset). RT-PCR confirmed the decrease in Sry
mRNA expression in vivo in rats infused with antisense
Sry ODN (Figure S2). Adjacent coronal brain sectionsstained with thionin (Nissl staining) revealed no differ-
ence in the number of cells resembling neurons in
treated versus untreated SNs (Figure S3). Furthermore,
females treated unilaterally with SRY antisense ODN
and contralaterally with sense ODN displayed no differ-
ence in the number of SN TH-ir neurons (Figure 2E), sug-
gesting that the Sry antisense cocktail used in this study
was specific for the Sry gene. These results suggest that
the reduction of TH-positive neurons in males was due
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417Table 1. Base Sequences and Positions of Antisense and Sense Oligodeoxynucleotides
ODN Sequence Target Region of mRNA
Antisense ODN 1 GCGCTTGACATGGCCCTCCAT +1 to +21
Antisense ODN 2 CATGGGGCGCTTGACATGGCCC +5 to +27
Antisense ODN 3 GGCCCTCCATGCTATCTAGA 210 to +10
Control (sense) ODN 1 ATGGAGGGCCATGTCAAGCGC +1 to +21
Control (sense) ODN 2 AGGGCCATGTCAAGCGCCCCAT +5 to +27
Control (sense) ODN 3 TCTAGATAGCATGGAGGGCC 210 to +10
Numbering starts at the initiation codon (the complementary triplet is underlined). Italic nucleotides are phosphorothioated.to a reduction in TH expression rather than a loss of TH-ir
neurons.
TH neurons in the SN project to the striatum and pro-
vide dopamine innervation. Thus, we tested whether Sry
antisense ODN infusions in the SN altered TH immuno-
staining in the striatum. Quantification of striatal TH-ir
by optical density demonstrated that treatment with
antisense ODN reduced TH immunostaining 26% in
comparison to SRY sense control sides (Figure 2F, p =
0.042).To demonstrate that the Sry actions on TH neurons
observed in our studies were specific, we investigated
whether the expression of Nur-related factor 1 (Nurr1)
was affected by our ODN infusions. Nurr1 is expressed
in the midbrain of developing mice at embryonic day
10.5, a time before TH is detected, and continues to be
expressed into adulthood. In Nurr1 knockout mice, de-
veloping neurons do not acquire dopaminergic markers
such as TH, and they ultimately die as development
progresses [11, 12]. Using adjacent brain slides thatFigure 2. Sry Antisense ODN Decreases the
Number of TH-ir Neurons in the SN
(A) Unilateral infusions of Sry sense ODN had
no effect on the number of TH-ir neurons and
served as an internal control.
(B Unilateral infusions of Sry antisense ODN
significantly reduced the number of TH-ir
neurons in the SN. Panels (A) and (B) show
TH-ir labeling from the same animal. Inset:
633 magnification.
(C) In a comparison of age-matched control
male and female rats, the number of TH-pos-
itive neurons in the SN of females was 20%
smaller than in males (mean 6 SEM; n = 4
for each group).
(D) Infusions of Sry antisense ODN in the SN
reduced the number of TH-ir neurons by
38% in comparison to sense-ODN-infused
SN (mean 6 SEM; n = 6).
(E) No difference between Sry antisense or
sense ODN was observed in the number of
TH-ir neurons in female rats (mean 6 SEM;
n = 4).
(F) Optical density measured a 26% decrease
in striatal TH-ir insides infused with Sry anti-
sense ODN versus those infused with sense
ODN (n = 5).
The scale bar represents 200 mm and 10 mm
(insets).
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418Table 2. Data from Sensorimotor-Behavioral Tests
Pre-ODN Infusion Post-ODN Infusion Recovery
Contra Ipsi I 2 C Contra Ipsi I 2 C Contra Ipsi I 2 C
Akinesia test (mean
number of
steps/10 s 6 SEM)
13.8 6 0.5 14.0 6 1.3 0.2 6 1.8 7.3 6 1.5 17.7 6 2.3 10.4 6 3.8 13.0 6 0.2 12.5 6 0.2 20.5 6 0.4
Limb-use asymmetry
test (mean percent
of limb use 6 SEM)
64.8 6 6.6 35.2 6 6.6 229.6 6 13.2 42.4 6 9.6 57.6 6 9.6 15.2 6 19.2 N/A N/A N/AFigure 3. Sry Downregulation in the SN Induces Deficits in Sensori-
motor Behaviors
(A) Akinesia tests revealed a significant decrease in the number of
steps taken by the contralateral forelimb in animals infused with
Sry antisense ODN. Unilateral downregulation of TH-positive neu-
rons caused animals to use their contralateral forelimbs by 58.8%
more than pre-Sry antisense ODN infusions. The overall index of
the akinesia score (I 2 C; mean 6 SEM) of 0.2 pre-ODN infusion re-
flects equal usage of both limbs. A significant, positive I2C score of
10.4 observed in post-ODN infusion experiments revealed a signifi-
cant bias for ipsilateral limb use. After 7 days of no ODN infusion, an
I2 C score of20.5 was observed, indicating full recovery of ipsilat-
eral limb usage.have shown differences in TH-ir in the SN, we did not
observe any differences between antisense-Sry-ODN-
infused brains and sense-ODN-infused brains (data
not shown) when we performed immunostaining with
Nurr1 antibody, suggesting that Sry does not directly af-
fect the expression of Nurr1.
SRY Effects on Sensorimotor Function
A decrease in SN dopamine causes quantifiable deficits
in sensorimotor function [13]. The effect of Sry antisense
ODN in the SN on specific motor functions was as-
sessed by the akinesia and limb-use asymmetry tests
[14]. In the akinesia test, animals with unilateral dopa-
mine depletions take fewer steps with their forelimb
contralateral to the depletion than they do with their ip-
silateral forelimb. Unilateral Sry antisense infusions re-
duced the number of steps taken by the contralateral
forelimbs by 58.8% (Table 2). A pre-ODN infusion I 2 C
(ipsilateral minus contralateral) score of 0.2 almost re-
flected equal usage of both forelimbs in stepping when
individual limbs were examined. However, after ODN in-
fusion, animals stepped more readily when ipsilateral
limbs were isolated, as represented by a significant pos-
itive I 2 C of 10.4, suggesting a statistically significant
deficit in contralateral limb usage (Figure 3A, p <
0.001). In addition, animals with unilateral Sry antisense
ODN infusions exhibited a similar decrease in TH ex-
pression in the SN, and this decrease was associated
with asymmetrical limb usage. In this test, we observed
a 26.4% decrease in contralateral limb usage after infu-
sion of Sry antisense ODN (Table 2). The negative I 2 C
score during pre-ODN infusion trials (229.66 13.2) indi-
cated an inherent bias by the animals toward favoring
their contralateral limb during cylinder exploration.
However, the tendency of limb usage switched to signif-
icantly favoring the ipsilateral limb that was associated
with sense ODN treatments during post-ODN trials
(Figure 3B, p = 0.013). Both sets of behavior tests ex-
hibited similar trends where animals uniformly de-
creased their contralateral limb usage and began
(B) Limb-use asymmetry test also revealed a 35% (mean6 SEM) de-
crease in limb use after infusions of Sry antisense ODN. Animals
demonstrated an ipsilateral-forelimb bias for usage in cylinder ex-
ploration after infusions of Sry antisense ODN, as determined by
a significant I 2 C score. The reluctance toward contralateral fore-
limb usage correlates with the downregulation of TH-positive
neurons in the SN. I 2 C is a single overall score that is obtained
by subtracting the use value of the contralateral limb from that of
the ipsilateral limb.
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419favoring the use of their ipsilateral limbs. These data
suggest that Sry downregulation in the SN reduces mo-
tor behaviors and are entirely consistent with the effect
of Sry on TH expression in the nigrostriatal system.
To verify that the decrease in TH-ir neurons in the SN,
and the consequent motor-behavior deficit observed in
our rats, were not attributed to generalized neurotoxicity
brought about by the administration of antisense ODN,
we assessed animals for motor behavior 7 days after ter-
mination of the antisense ODN treatment. Because the
effect of the ODN should be transient, some, if not all, re-
covery of both the activity of the Sry gene product and
motor behavior should occur. Using the akinesia test,
we observed no difference in contralateral or ipsilateral
limb usage when the I 2 C value returned to near zero
(20.5 6 0.7) (Figure 3A, p = 0.001) after 7 days of no
ODN infusions, indicating a complete recovery in con-
tralateral limb usage.
Conclusions
The experiments described here provide evidence that
the testis-determining gene Sry is expressed and trans-
lated in specific regions of the male mammalian adult
brain and that its role in the SN is to maintain biochem-
ical and motor functions of dopaminergic neurons.
These regions interestingly correspond to areas of the
brain that are subject to sexual differentiation [15]. Mod-
ulation of TH expression is complex and involves tran-
scriptional control, alternative RNA processing, and reg-
ulation of RNA stability [16]. Our data indicate that Sry
may control TH expression in the SN via both direct
and indirect mechanisms. Direct transcriptional control
of TH by Sry is possible in a subset of cells co-express-
ing the proteins and is supported by the reported Sry-
mediated activation of the TH gene promoter and by in
vitro transfection experiments [17]. Sry might act to in-
crease the number of TH-positive neurons in the SN to
a male level. When Sry is absent, as is the case in fe-
males, the number of TH-positive neurons remains at
a lower level. However, this does not explain why down-
regulation of Sry causes nigrostriatal deficits because
females do not exhibit overt motor dysfunction. An alter-
native view is thatSry could compensate for a factor that
is only present in females and maintains TH expression
in SN neurons. Estrogens have been shown to influence
TH in dopaminergic neurons: Short-term administration
of estradiol benzoate increases the levels of TH in dopa-
minergic neurons [18], and short-term ovariectomy re-
sults in a reversible decrease in the number of TH-posi-
tive neurons [19]. The role of Sry in the brain, to generate
sex differences in behavior, as well as to compensate for
other (e.g., hormonally induced) sex differences [20], is
consistent with the dual-function hypothesis for neural
sex differences [21]. The precise molecular mechanisms
by which Sry affects dopaminergic neurons remain to be
elucidated. Demonstration of a specific function for Sry
in the SN may provide a new model for a direct genetic
effect on a brain sexual dimorphism that is not mediated
by the effects of gonadal hormones.
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